Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Transient vascular occlusions in a zebrafish model of mycobacterial brain infection

  • Megan I. Hayes,

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Writing – original draft, Writing – review & editing

    Affiliation School of Biological Sciences, University of California, San Diego, La Jolla, United States of America

  • Sumedha Ravishankar,

    Roles Methodology, Writing – review & editing

    Affiliation School of Biological Sciences, University of California, San Diego, La Jolla, United States of America

  • Tariq Qayum,

    Roles Data curation, Formal analysis, Investigation

    Affiliation School of Biological Sciences, University of California, San Diego, La Jolla, United States of America

  • Victor Nizet,

    Roles Supervision, Writing – review & editing

    Affiliation Department of Pediatrics, University of California, San Diego, La Jolla, United States of America

  • Cressida A. Madigan

    Roles Conceptualization, Supervision, Writing – review & editing

    cmadigan@ucsd.edu

    Affiliation School of Biological Sciences, University of California, San Diego, La Jolla, United States of America

Abstract

Mycobacterial brain infection, for example tuberculous meningitis (TBM), caused by Mycobacterium tuberculosis, is a severe manifestation of tuberculosis that occurs when the bacteria invade the brain. In addition to extensive inflammation, vascular complications such as stroke frequently arise, significantly increasing the risk of disability and death. However, the mechanisms underlying these vascular complications remain poorly understood, as current knowledge is derived exclusively from human studies. To date, no animal model has been established to investigate the onset and progression of vascular pathology in TBM. Here, we use transparent zebrafish larvae to investigate vascular pathology during the early stages of TBM, establishing a model for studying vascular complications from mycobacterial brain infection. We find that mycobacteria preferentially attach to the lumen of vessel bifurcations and induce vessel enlargement. These attached microcolonies are sufficient to occlude brain blood vessels in the absence of an organized thrombus. The majority of microcolony-associated occlusions are transient and contribute to global hypoperfusion of the brain. These vascular disruptions lead to accumulation of oxidative stress and cell death in both the vasculature and neurons. Taken together, these findings demonstrate the occurrence of ischemic events during the early stages of mycobacterial brain infection and establish an animal model for studying vascular complications in TBM.

Introduction

Tuberculous meningitis (TBM), the deadliest manifestation of M. tuberculosis infection, claimed the lives of 78,300 children and adults in 2019 [13]. Cerebrovascular complications are particularly common in TBM and are associated with increased mortality [4,5]. These complications typically manifest as vasculitis and/or stroke and are strong predictors of disability and death in TBM [6].

TBM is thought to occur when M. tuberculosis disseminates beyond the initial infection site in the lungs and travels through the bloodstream to the brain [2]. Though still debated, various studies in the last several decades have begun unraveling the mechanism by which mycobacteria enter the brain parenchyma [79]. Once in the brain, M. tuberculosis infection is associated with the formation of myeloid cell aggregates, known eponymously as Rich foci, as well as vascular pathologies such as vasculitis and stroke [4,10]. While these findings have expanded our understanding of how mycobacteria enter the brain and initiate Rich foci formation, the mechanisms underlying TBM-associated vascular pathologies remain incompletely understood.

Much of our current knowledge regarding TBM’s impact on the brain’s vasculature derives from human magnetic resonance imaging (MRI), computed tomography (CT), and autopsy studies [5,11]. These studies have provided critical insights into the clinical presentation of TBM-associated vascular complications. However, findings are inconsistent across human studies. This is likely due to the underreporting of TBM, variable access to treatment, and the often-silent nature of vascular complications [2,5,12]. Furthermore, the observational nature of these human studies limits our ability to establish causal relationships between vascular pathology and TBM.

To elucidate the cellular and molecular mechanisms underlying vascular complications from mycobacterial brain infection, animal models are essential. Zebrafish larvae have been established as a useful model for studying mycobacterial brain infections [8,13]. In this model, larvae are infected with a pathogenic relative of M. tuberculosis, M. marinum, which replicates many features of tuberculosis infection in zebrafish larvae [8,13]. In addition to the extensive genetic tools available in zebrafish, their optical transparency at the larval stages allows for real-time visualization of mycobacterial brain infection in a live host [14,15]. This model presents an exciting opportunity to investigate the vascular complications of mycobacterial brain infection in vivo. Using live confocal imaging, we characterized the early vascular consequences of mycobacterial brain infection and found that microcolonies are associated with altered vascular morphology and transient occlusion of brain blood vessels. These disruptions contribute to a global reduction in cerebral blood flow velocity, as well as oxidative stress and cell death in both the vasculature and neurons. Our findings lay the groundwork for future investigations into vascular pathology in mycobacterial brain infection using the zebrafish model.

Materials and methods

Zebrafish husbandry and infections

Zebrafish husbandry and experiments were conducted in compliance with guidelines from the U.S. National Institutes of Health and approved by the University of California San Diego Institutional Animal Care and Use Committee (#S18135) and the Institutional Biosafety Committee of the University of California San Diego (#2452). All zebrafish work was performed by lab personnel that were trained and supervised by a University of California San Diego Animal Care Staff supervisor.

Wildtype AB strain zebrafish or transgenics in the AB background were used, including Tg(fliE:GFP) [16], Tg(flk:GFP) (ZDB-ALT-051114–10) [17], Tg(gata:DsRed) (ZDB-TGCONSTRCT-070117–38) [18], Tg(moesin:GFP) [19], Tg(cd41:GFP) (ZDB-TGCONSTRCT-190821–1) [20], and Tg(nbt:dsred) (ZDB-TGCONSTRCT-180817–1) [21]. All animals used for this study are larvae that are 7 days post fertilization or younger and of indeterminant sex. Larvae were anesthetized with 2.8% Syncaine (Syndel #886-86-2) prior to imaging or infection. Sibling fish from a single clutch were put in a petri dish and randomly selected for treatment groups. Study groups of approximately 30 larvae of indeterminate sex were infected, for a total of ~700 larvae. Infection is by injection of 10 nL into the caudal vein at 3 days post fertilization (dpf) using a capillary needle containing bacteria diluted in PBS + 2% phenol red (Sigma #P3532), as previously described [22]. Titered, single-cell suspensions were prepared for all M. marinum strains prior to infection by passing cell pellets from mid-log phase cultures (OD600 = 0.5 ± 0.1) repeatedly through a syringe to remove clumps, as described [22]. After caudal vein injections, the same needle was used to inject onto 7H10 (Sigma-Aldrich # M199) agar plates containing 50 μg/mL hygromycin B (ThermoFisher #10687010) or 50 μg/ml kanamycin (TCI #K0047) in triplicate to determine colony forming units (CFUs) in the inoculum. ~ 100−500 CFUs of wildtype M. marinum were administered to the larvae for experiments unless otherwise specified. After infection, larvae were housed at 28.5˚C, in an excess of zebrafish water containing ddH2O, 14.6 g/l sodium chloride (JT Baker #3628-F7), 0.63 g/l potassium chloride (Sigma-Aldrich #P3911), 1.83 g/l calcium chloride (G-Biosciences #RC-030), 1.99 g/l magnesium sulfate heptahydrate (MP Biomedicals #194833), methylene blue chloride (Millipore Sigma #284), and 0.003% 1-phenyl-2-thiourea (PTU, Sigma-Aldrich #189235) to prevent melanocyte development.

Infected and uninfected larvae were monitored daily for health and behavior. Transgenic larvae were screened on a fluorescence microscope and larvae negative for respective phenotypes were excluded. 1–4 larvae per infection group of 30 (~50 total for this study) were excluded and euthanized immediately if they displayed markers of death or poor prognosis, such as pericardial edema, yolk necrosis, and/or brain necrosis, or upon the conclusion of the experiment (up to 7 days post fertilization). 0–3 larvae per infection group of 30 (~35 total for this study) died due to infection prior to the experiment conclusion or any observed humane endpoint. At the end of the experiment, larvae were euthanized by immersion in chilled water for a minimum of 20 minutes following the loss of opercular movement and orientation, followed by an immersion in dilute sodium hypochlorite solution (500 mg/L).

Bacterial strains

M. marinum M strain (ATCC #BAA-535) expressing tdTomato or eBFP under control of the msp12 promoter [22,23], were grown in 50 μg/mL hygromycin B (ThermoFisher, #10687010) or 50 μg/mL kanamycin (TCI, # K0047) in liquid culture, consisting of 7H9 Middlebrook medium (Sigma-Aldrich, #M0178) supplemented with 2.5% oleic acid (Sigma, #O1008), 50% glucose, and 20% Tween-80 (Sigma, #P1754) [22]. Agar plates contained 7H10 Middlebrook agar (HiMedia, #M199) supplemented with oleic acid, albumin (Sigma, #A9647), dextrose, and Tween-80 [22].

Dextran and stain administration to zebrafish larvae

To visualize vessels in larvae without transgenic fluorescent vessels and to test luminal perfusion, 10 kDa Alexa647 Dextran (ThermoFisher, #D22914) was diluted to 1 mg/ml in PBS and injected into the caudal vein at the time of imaging. To visualize oxidative stress, cellROX (ThermoFisher, Cat# C10422) was diluted to 25 μM and injected into the hindbrain ventricle immediately prior to imaging. To visualize cell death, SYTOX deep red nucleic acid stain (ThermoFisher, Cat# S11380) was diluted to 10 μM and injected into the hindbrain ventricle.

Zebrafish larvae microscopy and image analysis

For confocal imaging, larvae were embedded in 1.2% low melting-point agarose (IBI Scientific #IB70051) [22]. A series of z stack images with a 0.82–1 µm step size were generated through the brain using the Zeiss LSM 880 laser scanning microscope with an LD C-Apochromat 40x objective. Imaris (Bitplane Scientific Software) was used to measure fluorescence intensity and construct three-dimensional surface renderings [24]. When events were compared between larvae or in paired vessels, identical confocal laser settings, software settings, and Imaris surface-rendering algorithms were used. For imaging blood vessels, transgenic animals with fluorescent blood vessels Tg(fliE:GFP) [16] or Tg(flk:GFP) [17], were used, or Alexa647 Dextran (ThermoFisher, #D22914) was injected intravenously.

For RBC tracking, larvae were embedded in 1.2% low melting-point agarose (IBI Scientific #IB70051) [22]. Fast frame imaging was performed on a Leica SP8 resonant scanning laser confocal microscope with a 25x water objective. Images were acquired at a frame rate of 83.3 fps for a total of 10.02 seconds. To track cells, the Imaris spot algorithm was used and applied at all time points to track individual RBCs.

Experimental reproducibility and statistical analysis

Many experiments were repeated multiple times to ensure reproducibility. The number of experimental replicates is indicated in the corresponding figure legend. If no number is listed, the experiment was conducted once. The exact number of larvae used for each experiment will depend on the experimental goal. However, a power analysis comparing two groups with incidence = 50%, alpha = 0.05, beta = 0.2, power = 80% indicates the need for 11 larvae, vessels, or microcolonies per group. The following statistical analyses were performed using Prism 8 (GraphPad): Student’s paired t-test, Chi-squared test, Fischer’s exact test and one-way ANOVA with multiple comparisons. The statistical tests used for each figure can be found in the corresponding figure legend. The n values for larvae and microcolonies are given below each corresponding graph.

Results

Mycobacteria attach to brain microvascular bifurcations and alter vessel morphology

Attachment of microcolonies to brain microvascular endothelial cells is thought to be one of the earliest steps in mycobacterial invasion of the brain [7]. In many neurovascular diseases, specific vessels or regions are disproportionately impacted. For instance, atherosclerosis, stroke, and aneurysms often occur at arterial bifurcations [25,26]. Similar patterns have been observed with bacteria that cause brain infections, such as Neisseria meningitides and group B Streptococcus, which adhere in specific locations and flow conditions [2729]. To investigate whether mycobacteria exhibit preferential attachment to the brain microvasculature, we use the natural fish pathogen, M. marinum (Mm), which shares 85% of its genes with M. tuberculosis [30]. Transgenic zebrafish larvae with green fluorescent vascular endothelial cells (flk:GFP) [31] were infected with red fluorescent M. marinum and imaged at 1 and 3 days post infection (dpi). At both timepoints, M. marinum microcolonies predominantly attached to vessel bifurcations rather than along straight vessels (Fig 1A-D). Given that increased turbulent blood flow at bifurcations is a contributor to aneurysm and stroke [25,26], our data suggest that similar hemodynamic forces may influence early interactions between M. marinum and brain blood vessels.

thumbnail
Fig 1. Mycobacteria microcolonies adhere to bifurcations and alter vessel morphology.

https://doi.org/10.1371/journal.pone.0332161.g001

(A) Rendered trace of brain vasculature of a fliE:GFP larva at 6 dpf. White points denote bifurcations. (B) Representative confocal images of straight (left) and bifurcated (right) vessels from larvae with green fluorescent blood vessels and blue fluorescent M. marinum (Mm). Arrowhead, attached microcolony. Arrow, bifurcation. (C,D) Proportion of microcolonies attached (C) and crossing (D) at straight (black) or bifurcated (white) vessels at 1 and 3 dpi. Observed (obs.) proportion is compared to expected (exp.) proportion normalized to total straight or bifurcated vessel length found in the entire brain. Mm observed attachment and crossing at bifurcated vessels is significantly higher than expected at 1 and 3 dpi. Fischer’s exact test. (E) Representative confocal images of uninfected (top), and infected (bottom) vessels from larvae with green fluorescent blood vessels and blue fluorescent Mm at 3 dpi. Dashed line, diameter of vessel measure in (F). (F) Quantification of maximum diameter of infected and uninfected vessels from the same larvae at 3 dpi. Infected vessels have a significantly greater diameter compared to uninfected vessels. Horizontal bars, means; paired t-test. Scale bar, 10 μm throughout. See S1 Fig for experimental design.

We next examined vascular morphology following mycobacterial attachment. Cerebral angiography in TBM patients frequently reveals beaded vessels with alternating regions of narrowing and dilation [5]. To assess whether the zebrafish vasculature exhibits similar morphological changes, transgenic larvae expressing a green fluorescent endothelial marker (flk:moesin-GFP) [19] were infected with blue fluorescent M. marinum and imaged at 3 dpi. Compared to contralateral uninfected vessels in the same larva, microcolony-associated vessels displayed significantly increased diameters around bacterial microcolonies (Fig 1E-F), closely resembling the beading morphology observed in TBM patients. These findings indicate that mycobacterial brain infection in zebrafish recapitulates key vascular patterns and morphological features associated with TBM vascular pathology in humans.

Mycobacterial attachment is sufficient to obstruct blood flow

Infarctions are areas of necrotic tissue resulting from prolonged ischemia and are a hallmark of TBM [32]. However, the precise mechanism of how they occur in TBM remains unclear [4]. Thrombosis has been implicated as a potential contributor to infarction early in brain infection [3335], but reports vary on the frequency of organized thrombus formation [36]. Organized thrombi typically consist of red blood cells (RBCs), thrombocytes, neutrophil extracellular traps, and fibrin [37]. Once formed, thrombi can occlude blood vessels, restricting oxygen and glucose perfusion and ultimately leading to infarction [38].

To investigate the role of thrombosis during mycobacterial brain infection, we investigated the role of thrombi components, starting with RBCs. Blue fluorescent M. marinum was intravenously injected into transgenic zebrafish larvae with green fluorescent endothelial cells and red fluorescent RBCs (flk1:GFP;gata1a:DsRed) [18,31]. Confocal imaging revealed that RBCs move freely through most uninfected vessels. This is seen as diagonal streaks of red caused by RBCs flowing quickly through the vessel during image acquisition (Fig 2A-C). In contrast, most infected vessels contained stagnant RBCs, suggesting occlusion of the vessel (Fig 2A-C). Vessels infected by microcolonies contained immobilized RBCs around the bacteria (Fig 2D-E). However, in other cases vessel occlusion occurred despite the absence of immobilized RBCs (Fig 2D-E). Notably, microcolonies alone were as likely to occlude vessels as those with immobilized RBCs (Fig 2E). Among all infected vessels, blood flow was absent or limited compared to uninfected vessels (Fig 2E), although some uninfected vessels also lacked blood flow (Fig 2C). No immobilized RBCs were observed in vessels without a microcolony present.

thumbnail
Fig 2. Mycobacteria microcolonies occlude brain blood vessels.

https://doi.org/10.1371/journal.pone.0332161.g002

(A-B) Representative confocal images of the larval brain vasculature with green fluorescent blood vessels, red fluorescent red blood cells (RBCs) and infected with blue fluorescent M. marinum (Mm). Dashed box indicates location of uninfected (top) and infected (bottom) vessels in (B). Arrowhead, stagnant RBCs. (C) Proportion of vessels with or without blood flow in infected or uninfected vessels. Significantly fewer infected vessels had blood flow compared to uninfected vessels; Fisher’s exact test. Representative of 2 independent experiments. (D) Brain blood vessels (green) with or without associated microcolonies (blue) and/or RBCs (red). Upper left, RBCs in uninfected vessel. Upper right, microcolony with stagnant RBCs. Lower left, infected vessel without RBCs. Lower right, uninfected vessel. (E) Proportion of infected blood vessels with or without blood flow around microcolonies associated or not associated with RBCs; ns: not significant, Fisher’s exact test. Representative of 2 independent experiments. (F) Representative confocal images of larva with green fluorescent blood vessels and red fluorescent RBCs, infected or not with blue fluorescent Mm. Dashed line indicates diameter of infected vessel with (top) or without (bottom) stagnant RBCs quantified in (G). (G) Quantification of vessel diameter in infected vessels with or without stagnant RBCs. Infected vessels associated with stagnant RBCs have a significantly increased diameter. Horizontal bars, means; Student’s t-test. Representative of 2 independent experiments. (H) Representative confocal images of blue fluorescent Mm-infected larva with green fluorescent thrombocytes (pseudo-colored magenta) and intravenously injected Alexafluor647 dextran (pseudo-colored green). (I) Proportion of infected vessels associated with stagnant RBCs and/or thrombocytes. (J) Representative confocal images of blue fluorescent Mm-infected larva with intravenously injected Alexafluor647 dextran (pseudo-colored green). (K) Proportion of infected or uninfected vessels with no (grey), partial (white) or complete (black) dextran perfusion. Chi-squared test. Scale bar, 10 μm throughout.

Vessel occlusion often leads to vessel dilation due to increased intraluminal pressure and weakening of the vessel wall [39]. While infected vessels were generally wider than uninfected vessels (Fig 1E-F), vessels with immobilized RBCs exhibited significantly greater diameters than infected vessels without RBCs (Fig 2F-G), suggesting that RBC accumulation contributes to vascular dilation.

Another mediator of coagulation and thrombosis are thrombocytes [40]. To examine their involvement in mycobacterial brain infection, we intravenously injected blue fluorescent M. marinum into transgenic larvae with green fluorescent thrombocytes and red fluorescent RBCs (cd41:GFP; gata1a:DsRed) [20]. Of vessels with microcolonies, only 19% were associated with thrombocytes, while 6% had both RBCs and thrombocytes (Fig 2H-I), indicating that thrombocytes may play a minor role in vessel occlusion.

In addition to RBC accumulation, vessel occlusion can restrict the passage of luminal contents such as glucose, a critical substrate for neuronal metabolism [38]. To assess vessel permeability, larvae infected with blue-fluorescent M. marinum were injected intravenously with a 10 kDa Alexafluor647 dextran. While all uninfected vessels showed complete dextran perfusion, infected vessels displayed varying degrees of restricted perfusion (Fig 2J). Among infected vessels, 31% maintained full dextran perfusion, 44% exhibited partial perfusion, and 25% were entirely non-perfused (Fig 2J-K). These findings indicate that mycobacterial attachment to brain vessels is sufficient to impair perfusion of luminal contents without thrombus formation.

Mycobacteria-associated occlusions are transient

Vascular occlusion has been observed in TBM patients, yet its duration remains unclear [41]. To investigate the kinetics of occlusion formation during mycobacterial infection, transgenic larvae with fluorescent vascular endothelial cells and RBCs (flk1:GFP;gata1a:DsRed) were infected with blue fluorescent M. marinum, and fast-frame imaging was performed for 10 seconds. RBCs remained stagnant in infected vessels (Fig 3A-B), confirming vessel occlusion as observed in still images (Fig 2). In contrast, RBCs in uninfected vessels, from either uninfected or infected larvae, exhibited continuous blood flow (Fig 3A-B). Interestingly, RBC velocity was significantly reduced in uninfected brain vessels from infected larvae compared to those from uninfected larvae (Fig 3A, C), mirroring the hypoperfusion observed in human TBM [42].

thumbnail
Fig 3. Mycobacteria-associated vessel occlusions are transient.

https://doi.org/10.1371/journal.pone.0332161.g003

(A) Representative still images from fast frame confocal imaging of larvae with green fluorescent blood vessels and red fluorescent RBCs, infected with blue fluorescent Mm. Tracks of individual RBCs are overlain over the vessel and color coded from blue (0 μm/second) to red (500 μm/second). (B, C) Quantification of RBC displacement (B) and velocity (C) from fast frame imaging. Significantly more uninfected vessels from uninfected and infected fish have RBC displacement compared to infected vessels. Uninfected vessels from uninfected fish have significantly higher RBC velocity compared to uninfected vessels from infected fish and infected vessels. Horizontal bars, means; one-way ANOVA with multiple comparisons. (D) Sequential images from time lapse imaging. Arrowheads, microcolonies obstructing blood flow. t, hours:minutes after start of time-lapse video recording. (E) Sequential images of same microcolony at 1, 2, and 3 dpi. Arrowheads, microcolony obstructing blood flow. Representative of 2 independent experiments. (F) Quantification of number of Mm associated occlusions at 1, 2, and 3 dpi. There are significantly more Mm associated with unperfused vessels at 2 dpi and 3 dpi compared to 1 dpi. Horizontal bars, means; one-way ANOVA with multiple comparisons. (G) Proportion of infected vessels that are perfused by RBCs at 1, 2, and 3 dpi. ns: not significant; Chi-squared test. (H) Proportion of infected vessels that have a new occlusion (black), or have had an occlusion for 1 (grey) and 2 + days (white). ns: not significant; Chi-squared test. Scale bar, 10 μm throughout.

To determine how soon microcolonies adhere to vessels and block blood flow following infection, larvae were infected and immediately time lapse imaged over the next 14 hours. This revealed that microcolonies adhered to the brain endothelium and transiently blocked blood flow within the first 14 hours of infection in the blood (Fig 3D, S4 Video). All microcolonies detached and reentered circulation within minutes to ~3 hours of attaching to the vasculature. After detachment, previously occluded vessels regained blood flow (Fig 3D), indicating that early occlusions are transient.

Severe cerebral thrombosis can often last several days to weeks [32]. To assess longer-term occlusion, larvae were sequentially imaged at 1, 2, and 3 dpi. The number of mycobacteria-associated occlusions increased over time (Fig 3F), though most occlusions lasted for only one day (Fig 3G-H). These findings indicate that the majority of microcolony-associated occlusions are transient.

Mycobacteria in vessels is associated with oxidative stress

The ultimate consequence of vascular occlusion is the formation of an infarct, an area of necrotic tissue resulting from prolonged ischemia [32]. Infarcts have been reported in 13% to 57% of TBM cases based on MRI studies and autopsy findings [5]. During ischemic stroke, decreased oxygen levels increase the formation of reactive oxygen species (ROS), which drives oxidative stress and leads to cell death and infarct formation [43]. Given that transient mycobacterial occlusions disrupt blood flow, we sought to determine whether these events induce oxidative stress and subsequent cell death in the brain.

To assess oxidative stress, transgenic zebrafish larvae expressing green fluorescent endothelial cells and red neurons (flk1:GFP;nbt:DsRed) [21] were intravenously injected with either blue fluorescent M. marinum or phosphate buffered saline (PBS) as a control. Prior to imaging, larvae were injected in the hindbrain ventricle with cellROX, a probe that fluoresces when oxidized by ROS. Imaging at 2 dpi, when many microcolonies have adhered to brain blood vessels, revealed significantly higher oxidative stress in infected larvae compared to PBS-injected controls (Fig 4A-B). The oxidative stress was particularly pronounced in both neurons and endothelial cells near vessels containing a microcolony (Fig 4C-D).

thumbnail
Fig 4. Oxidative stress increases in infected larvae prior to mycobacterial entry into the brain.

https://doi.org/10.1371/journal.pone.0332161.g004

(A) Representative confocal images of PBS injected (top) or blue fluorescent M. marinum (Mm) infected (bottom) 3 dpi larva with green fluorescent blood vessels, red fluorescent neurons, and injected with cellROX. (B) Total cellROX staining volume in infected compared to uninfected brains at 3 dpi. Infected larvae have significantly greater total cellROX volume compared to uninfected. Horizontal bars, means; student’s t-test. (C,D) CellROX staining volume localized to neurons (C) and brain blood vessels (D) in infected compared to uninfected brains at 3 dpi. Infected larvae have significantly greater cellROX volume in neurons and vessels compared to uninfected. Horizontal bars, means; student’s t-test. (E) Representative confocal images of PBS mock injected (top) or blue fluorescent M. marinum infected (bottom) 3 dpi larva with green fluorescent blood vessels, red fluorescent neurons, and injected with SYTOX. (F) Total SYTOX staining volume in infected compared to uninfected brains at 3 dpi. Infected larvae have significantly greater total SYTOX volume compared to uninfected. Horizontal bars, means; student’s t-test. Scale bar, 10 μm throughout.

To determine whether the observed increase in ROS led to cell death, we performed a parallel experiment using SYTOX, which marks dying cells. Transgenic larvae with fluorescent endothelial cells and neurons (flk1:GFP;nbt:DsRed) [21] were intravenously injected with either M. marinum or PBS, followed by hindbrain ventricle injection of SYTOX just before imaging. Compared to PBS-injected larvae, infected larvae exhibited a significantly higher number of SYTOX-positive cells (Fig 4E-F), indicating increased cell death in the brain parenchyma.

Together, these findings demonstrate that mycobacterial attachment to the brain vasculature is associated with increased oxidative stress and neuronal damage. The transient nature of these occlusions suggests that repeated cycles of obstruction and reperfusion may contribute to cumulative oxidative damage, potentially playing a key role in neurovascular pathology in mycobacterial brain infection.

Discussion

In characterizing neurovascular events during the early stages of mycobacterial brain infection, we have identified key vascular complications associated with M. marinum infection in the zebrafish model. Our findings demonstrate that M. marinum preferentially attaches to vessel bifurcations in the brain, leading to both global hypoperfusion and local vessel obstruction. These disruptions contribute to oxidative stress accumulation in both the brain vasculature and neurons. Our study establishes the zebrafish as a valuable model for investigating the vascular complications of mycobacterial brain infection.

Until now, our understanding of TBM-associated vascular pathology has relied on clinical observations [5,11,41]. These studies provide valuable documentation of TBM’s human manifestations and inform diagnostic and treatment strategies. However, clinical observations have inherent limitations. Due to the overlap between TBM symptoms and those of other meningitis, as well as the variability of current culturing techniques, TBM diagnosis is often delayed [2]. As a result, most of our understanding of TBM-related vascular pathologies pertains to advanced stages of infection or post-mortem findings, leaving the earliest vascular events poorly defined. Additionally, determining causal relationships and molecular mechanisms in human studies is challenging. Animal models provide invaluable opportunities for controlled investigations to uncover causality at the cellular and molecular level. Many studies have demonstrated the utility of zebrafish in modeling TB pathogenesis [13,22,44,45]. Our findings further support the zebrafish model as a platform for investigating vascular pathology in mycobacterial brain infection, offering new insights into disease progression.

A debated topic in TBM pathology is the role and prevalence of organized thrombi in vascular occlusions. Human studies have reported conflicting findings regarding the presence of organized thrombi and the duration of vascular events leading to infarction [5,3336]. Our study demonstrates that organized thrombus formation is uncommon, and early mycobacteria associated occlusions are predominantly transient. However, we also found occasional thrombus-associated occlusions that persisted for at least 3 days (Fig 3). The presence of multiple occlusion mechanisms in our model may help reconcile discrepancies in human studies, as differences in sampling timepoints and disease progression could account for the variability in thrombus detection.

Our findings demonstrate that attached M. marinum microcolonies can be sufficient to prevent blood flow. In our own system, typical M. marinum microcolonies have a maximum diameter of ~5 μm by 3 dpi, while the average maximum diameter of the associated brain blood vessel is ~ 8 μm. Meanwhile, the typical diameter of a zebrafish red blood cell is ~ 7–8 μm [46]. Therefore, it is possible that microcolony attachment prevents blood flow by creating a physical barrier within the vessel lumen. However, vessel injury and ROS accumulation have also been implicated in RBC accumulation in vessels [47,48]. We have found that infected larvae have increased ROS in vessels and the brain parenchyma during mycobacterial brain infection (Fig 4). Therefore, it is possible that vessel injury from the attached microcolony and/or increased ROS contribute to the RBC accumulation we observe around microcolonies. Further studies are needed to unravel the causal relationship between vessel injury, ROS production, and RBC accumulation in our model of mycobacterial brain infection.

Vascular complications are a major contributor to long-term disability and death in TBM [6]. However, our current understanding of the onset and progression of these complications remains limited. This knowledge gap hampers the development of effective diagnostic tools and therapeutic interventions [5]. By extending the use of zebrafish larvae as a model for vascular pathology in mycobacterial brain infection, our work provides a powerful tool for further mechanistic investigations. Future studies leveraging this model may elucidate novel therapeutic targets, improving clinical outcomes for TBM patients.

Supporting information

S1 Fig. Experimental design showing the work flow for zebrafish infection experiments.

At 3 dpf, healthy transgenic larvae are infected in the caudal vein with M. marinum or injected with PBS. At 3 dpi, confocal imaging of larvae is used to assess infection and vessel changes in the brain.

https://doi.org/10.1371/journal.pone.0332161.s001

(PDF)

S1 video. Fast frame 83.3 fps confocal imaging of an uninfected green fluorescent blood vessel (flk1:GFP) and red fluorescent RBCs (gata1a:DsRed) in a PBS-injected larva.

https://doi.org/10.1371/journal.pone.0332161.s002

(MOV)

S2 video. Fast frame 83.3 fps confocal imaging of an uninfected green fluorescent blood vessel (flk1:GFP) and red fluorescent RBCs (gata1a:dsRed) in a larva infected with blue fluorescent Mm.

https://doi.org/10.1371/journal.pone.0332161.s003

(MOV)

S3 video. Fast frame 83.3 fps confocal imaging of an infected green fluorescent blood vessel (flk1:GFP) and red fluorescent RBC (gata1a:dsRed) in a larva infected with blue fluorescent Mm.

https://doi.org/10.1371/journal.pone.0332161.s004

(MOV)

S4 video. Time lapse confocal imaging of a larva with green fluorescent blood vessels and red fluorescent RBCs infected with blue fluorescent Mm.

Time lapse images were acquired every 5 minutes for 15 hours.

https://doi.org/10.1371/journal.pone.0332161.s005

(MOV)

Acknowledgments

The authors thank Richard Daneman for discussion, mentorship, and guidance throughout the project; and Morgan Reitano, Liam Morrill, and the University of California, San Diego aquatics facility staff for zebrafish maintenance.

References

  1. 1. Chiang SS, Khan FA, Milstein MB, Tolman AW, Benedetti A, Starke JR, et al. Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(10):947–57. pmid:25108337
  2. 2. Wilkinson RJ, Rohlwink U, Misra UK, van Crevel R, Mai NTH, Dooley KE, et al. Tuberculous meningitis. Nat Rev Neurol. 2017;13(10):581–98. pmid:28884751
  3. 3. Seid G, Alemu A, Dagne B, Gamtesa DF. Microbiological diagnosis and mortality of tuberculosis meningitis: Systematic review and meta-analysis. PLoS One. 2023;18(2):e0279203. pmid:36795648
  4. 4. Kalita J, Misra UK, Nair PP. Predictors of stroke and its significance in the outcome of tuberculous meningitis. J Stroke Cerebrovasc Dis. 2009;18(4):251–8. pmid:19560677
  5. 5. Misra UK, Kalita J, Maurya PK. Stroke in tuberculous meningitis. J Neurol Sci. 2011;303(1–2):22–30. pmid:21272895
  6. 6. Andronikou S, Wilmshurst J, Hatherill M, VanToorn R. Distribution of brain infarction in children with tuberculous meningitis and correlation with outcome score at 6 months. Pediatr Radiol. 2006;36(12):1289–94. pmid:17031634
  7. 7. Be NA, Bishai WR, Jain SK. Role of Mycobacterium tuberculosis pknD in the pathogenesis of central nervous system tuberculosis. BMC Microbiol. 2012;12:7. pmid:22243650
  8. 8. van Leeuwen LM, Boot M, Kuijl C, Picavet DI, van Stempvoort G, van der Pol SMA, et al. Mycobacteria employ two different mechanisms to cross the blood-brain barrier. Cell Microbiol. 2018;20(9):e12858. pmid:29749044
  9. 9. Be NA, Lamichhane G, Grosset J, Tyagi S, Cheng Q-J, Kim KS, et al. Murine model to study the invasion and survival of Mycobacterium tuberculosis in the central nervous system. J Infect Dis. 2008;198(10):1520–8. pmid:18956986
  10. 10. Rich A, McCordock H. The Pathogenesis of Tuberculosis Meningitis. Bullet Johns Hopkins Hospital. 1933;52:5–37.
  11. 11. Schoeman J, Hewlett R, Donald P. MR of childhood tuberculous meningitis. Neuroradiology. 1988;30(6):473–7. pmid:3226532
  12. 12. Chan KH, Cheung RTF, Lee R, Mak W, Ho SL. Cerebral infarcts complicating tuberculous meningitis. Cerebrovasc Dis. 2005;19(6):391–5. pmid:15863982
  13. 13. Takaki K, Ramakrishnan L, Basu S. A zebrafish model for ocular tuberculosis. PLoS One. 2018;13(3):e0194982. pmid:29584775
  14. 14. Kalueff AV, Stewart AM, Gerlai R. Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol Sci. 2014;35(2):63–75. pmid:24412421
  15. 15. Cosma CL, Swaim LE, Volkman H, Ramakrishnan L, Davis JM. Zebrafish and frog models of Mycobacterium marinum infection. Curr Protoc Microbiol. 2006;Chapter 10:Unit 10B.2. pmid:18770575
  16. 16. Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol. 2002;248(2):307–18. pmid:12167406
  17. 17. Liu J, Fraser SD, Faloon PW, Rollins EL, Vom Berg J, Starovic-Subota O, et al. A betaPix Pak2a signaling pathway regulates cerebral vascular stability in zebrafish. Proc Natl Acad Sci U S A. 2007;104(35):13990–5. pmid:17573532
  18. 18. Traver D, Paw BH, Poss KD, Penberthy WT, Lin S, Zon LI. Transplantation and in vivo imaging of multilineage engraftment in zebrafish bloodless mutants. Nat Immunol. 2003;4(12):1238–46. pmid:14608381
  19. 19. Wang Y, Kaiser MS, Larson JD, Nasevicius A, Clark KJ, Wadman SA, et al. Moesin1 and Ve-cadherin are required in endothelial cells during in vivo tubulogenesis. Development. 2010;137(18):3119–28. pmid:20736288
  20. 20. Lin H-F, Traver D, Zhu H, Dooley K, Paw BH, Zon LI, et al. Analysis of thrombocyte development in CD41-GFP transgenic zebrafish. Blood. 2005;106(12):3803–10. pmid:16099879
  21. 21. Peri F, Nüsslein-Volhard C. Live imaging of neuronal degradation by microglia reveals a role for v0-ATPase a1 in phagosomal fusion in vivo. Cell. 2008;133(5):916–27. pmid:18510934
  22. 22. Takaki K, Davis JM, Winglee K, Ramakrishnan L. Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafish. Nat Protoc. 2013;8(6):1114–24. pmid:23680983
  23. 23. Cosma CL, Klein K, Kim R, Beery D, Ramakrishnan L. Mycobacterium marinum Erp is a virulence determinant required for cell wall integrity and intracellular survival. Infect Immun. 2006;74(6):3125–33. pmid:16714540
  24. 24. Yang C-T, Cambier CJ, Davis JM, Hall CJ, Crosier PS, Ramakrishnan L. Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages. Cell Host Microbe. 2012;12(3):301–12. pmid:22980327
  25. 25. Hademenos GJ, Massoud TF. Biophysical mechanisms of stroke. Stroke. 1997;28(10):2067–77. pmid:9341720
  26. 26. Chalouhi N, Hoh BL, Hasan D. Review of cerebral aneurysm formation, growth, and rupture. Stroke. 2013;44(12):3613–22. pmid:24130141
  27. 27. Coureuil M, Lécuyer H, Bourdoulous S, Nassif X. A journey into the brain: insight into how bacterial pathogens cross blood-brain barriers. Nat Rev Microbiol. 2017;15(3):149–59. pmid:28090076
  28. 28. Mairey E, Genovesio A, Donnadieu E, Bernard C, Jaubert F, Pinard E, et al. Cerebral microcirculation shear stress levels determine Neisseria meningitidis attachment sites along the blood-brain barrier. J Exp Med. 2006;203(8):1939–50. pmid:16864659
  29. 29. Ravishankar S, Tuohey SM, Ramos NO, Uchiyama S, Hayes MI, Nizet V, et al. Group B streptococci lyse endothelial cells to infect the brain in a zebrafish meningitis model. Cold Spring Harbor Laboratory. 2024.
  30. 30. Tobin DM, Ramakrishnan L. Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis. Cell Microbiol. 2008;10(5):1027–39. pmid:18298637
  31. 31. Choi J, Dong L, Ahn J, Dao D, Hammerschmidt M, Chen J-N. FoxH1 negatively modulates flk1 gene expression and vascular formation in zebrafish. Dev Biol. 2007;304(2):735–44. pmid:17306248
  32. 32. Ulivi L, Squitieri M, Cohen H, Cowley P, Werring DJ. Cerebral venous thrombosis: a practical guide. Pract Neurol. 2020;20(5):356–67. pmid:32958591
  33. 33. Lammie GA, Hewlett RH, Schoeman JF, Donald PR. Tuberculous cerebrovascular disease: a review. J Infect. 2009;59(3):156–66. pmid:19635500
  34. 34. Deshpande DH, Bharucha EP, Mondkar VP. Tuberculous meningitis in adults. (A clinico-pathological study of 18 cases). Neurol India. 1969;17(1):28–34. pmid:5783665
  35. 35. Poltera AA. Thrombogenic intracranial vasculitis in tuberculous meningitis. A 20 year “post mortem” survey. Acta Neurol Belg. 1977;77(1):12–24. pmid:842274
  36. 36. Dalal PM. Observations on the involvement of cerebral vessels in tuberculous meningitis in adults. Adv Neurol. 1979;25:149–59. pmid:506839
  37. 37. Jolugbo P, Ariëns RAS. Thrombus composition and efficacy of thrombolysis and thrombectomy in acute ischemic stroke. Stroke. 2021;52(3):1131–42. pmid:33563020
  38. 38. Campbell BCV, De Silva DA, Macleod MR, Coutts SB, Schwamm LH, Davis SM, et al. Ischaemic stroke. Nat Rev Dis Primers. 2019;5(1):70. pmid:31601801
  39. 39. Ngoepe MN, Frangi AF, Byrne JV, Ventikos Y. Thrombosis in cerebral aneurysms and the computational modeling thereof: a review. Front Physiol. 2018;9:306. pmid:29670533
  40. 40. Koupenova M, Clancy L, Corkrey HA, Freedman JE. Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ Res. 2018;122(2):337–51. pmid:29348254
  41. 41. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Serial CT scanning in childhood tuberculous meningitis: prognostic features in 198 cases. J Child Neurol. 1995;10(4):320–9. pmid:7594269
  42. 42. Misra UK, Kalita J, Das BK. Single photon emission computed tomography in tuberculous meningitis. Postgrad Med J. 2000;76(900):642–5. pmid:11009579
  43. 43. Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16(1):142. pmid:31291966
  44. 44. Davis JM, Clay H, Lewis JL, Ghori N, Herbomel P, Ramakrishnan L. Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity. 2002;17(6):693–702. pmid:12479816
  45. 45. Ramakrishnan L. The zebrafish guide to tuberculosis immunity and treatment. Cold Spring Harb Symp Quant Biol. 2013;78:179–92. pmid:24643219
  46. 46. Kulkeaw K, Sugiyama D. Zebrafish erythropoiesis and the utility of fish as models of anemia. Stem Cell Res Ther. 2012;3(6):55. pmid:23257067
  47. 47. Wang Q, Zennadi R. Oxidative Stress and Thrombosis during Aging: The Roles of Oxidative Stress in RBCs in Venous Thrombosis. Int J Mol Sci. 2020;21(12):4259. pmid:32549393
  48. 48. Du VX, Huskens D, Maas C, Al Dieri R, de Groot PG, de Laat B. New insights into the role of erythrocytes in thrombus formation. Semin Thromb Hemost. 2014;40(1):72–80. pmid:24356930